Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Seed | Alive

Total Raised


Last Raised

$2.37M | 7 yrs ago

About HR-BIO

Developer of cell therapy technologies. The company develops technologies in cell therapy and its implication on clinical studies and medical cosmetology. Its research focus includes the comparison, verification, and reactivation of stem cells.

HR-BIO Headquarters Location

Jingyue District 999 Jinbi Road

Changchun, Jilin, 130021,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing HR-BIO

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

HR-BIO is included in 2 Expert Collections, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

HR-BIO Patents

HR-BIO has filed 1 patent.

The 3 most popular patent topics include:

  • Benzochromenes
  • Cannabinoids
  • Designer drugs
patents chart

Application Date

Grant Date


Related Topics




Cannabinoids, Designer drugs, Phenols, Piperidines, Benzochromenes


Application Date


Grant Date



Related Topics

Cannabinoids, Designer drugs, Phenols, Piperidines, Benzochromenes



  • Where is HR-BIO's headquarters?

    HR-BIO's headquarters is located at Jingyue District, Changchun.

  • What is HR-BIO's latest funding round?

    HR-BIO's latest funding round is Seed.

  • How much did HR-BIO raise?

    HR-BIO raised a total of $2.37M.

  • Who are the investors of HR-BIO?

    Investors of HR-BIO include Aeon Life Insurance.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.